Delivery Order SPE2DB22D3501-SPE2DB24FWS01
Award Date
8/19/24
Potential Completion Date
9/10/24
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,336.54 firm fixed-price delivery order contract is for the supply of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a specialty medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,673.08, is for the delivery of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a prescription medication. The contract has an ultimate completion date of May 29, 2025. AmerisourceBergen Drug Corp is the prime contractor on this award and holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,673.08 firm fixed-price delivery order is for the supply of HEMLIBRA 105 MG/0.7 ML VIAL 0.7ML, a specialty pharmaceutical product. The contract has an ultimate completion date of April 29, 2025 and was awarded on April 8, 2025. This contract award is a part of a larger Indefinite Delivery Contract (IDC) valued...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $33,409.40, is for the delivery of HEMLIBRA 150 MG/ML VIALML, a medication used in the treatment of hemophilia. The contract has a completion date of June 21, 2024, and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, with an ID of SPE2DB22D3301|SPE2DB25FX4KD, was issued by the Defense Logistics Agency (DLA) for the delivery of HEMLIBRA 150 MG/ML VIALML, a specialty pharmaceutical product. The $16,704.72 firm-fixed-price delivery order has an ultimate completion date of November 18, 2024 and was awarded on October 25, 2024 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside for any specific business...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $3,224.98 and covers the delivery of 2,400 units of HUMATE-P, a medication used to treat von Willebrand disease. The contract is a firm fixed-price delivery order with a completion date of March 31, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,577.28 Delivery Order is for the supply of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 16, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of HUMALOG 100 UNIT/ML VIAL 10ML, a prescription medication. The $1,639.44 delivery order was awarded on May 16, 2024 by the Defense Logistics Agency (DLA), a Defense agency, and has an ultimate completion date of May 17, 2024. The contract is a firm fixed price delivery order with no set-aside designation. Amerisourcebergen...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,590.20 firm-fixed-price contract is for the supply of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. The award has an ultimate completion date of July 22, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,887.48, is for the delivery of the pharmaceutical product Humira (CF) Pen 40 mg/0.4 mL. The contract is a firm fixed-price, non-set-aside award with a performance period through May 2, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...